Literature DB >> 18954284

Immunity to respiratory viruses.

Jacob E Kohlmeier1, David L Woodland.   

Abstract

The respiratory tract is characterized by an extensive surface area that is in direct contact with the environment, posing a significant problem for effective immune surveillance. Yet most respiratory pathogens are quickly recognized and controlled by a coordinated response involving the innate and adaptive arms of the immune system. The investigation of pulmonary immunity to respiratory viruses during a primary infection has demonstrated that multiple innate and adaptive immune mechanisms are necessary for efficient antiviral responses, and the inhibition of any single mechanism can have disastrous consequences for the host. Furthermore, the investigation of recall responses in the lung has shown that protection from a secondary challenge infection is a complex and elegant process that occurs in distinct stages. In this review, we discuss recent advances that describe the roles of individual components during primary and secondary responses to respiratory virus infections and how these discoveries have added to our understanding of antiviral immunity in the lung.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18954284     DOI: 10.1146/annurev.immunol.021908.132625

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  137 in total

1.  Lymphocytic choriomeningitis virus persistence promotes effector-like memory differentiation and enhances mucosal T cell distribution.

Authors:  Lalit K Beura; Kristin G Anderson; Jason M Schenkel; Jeremiah J Locquiao; Kathryn A Fraser; Vaiva Vezys; Marion Pepper; David Masopust
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

2.  Lung development and the host response to influenza A virus are altered by different doses of neonatal oxygen in mice.

Authors:  Bradley W Buczynski; Min Yee; B Paige Lawrence; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-09       Impact factor: 5.464

3.  Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses.

Authors:  Ryan A Langlois; Andrew Varble; Mark A Chua; Adolfo García-Sastre; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

4.  Effects of aging on the adaptive immune response to respiratory virus infections.

Authors:  Ross B Fulton; Steven M Varga
Journal:  Aging health       Date:  2009-12-01

5.  Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections.

Authors:  Hazem E Ghoneim; Paul G Thomas; Jonathan A McCullers
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

6.  Antiviral instruction of bone marrow leukocytes during respiratory viral infections.

Authors:  Tamar Hermesh; Bruno Moltedo; Thomas M Moran; Carolina B López
Journal:  Cell Host Microbe       Date:  2010-05-20       Impact factor: 21.023

7.  A broad-spectrum, efficient and nontransgenic approach to control plant viruses by application of salicylic acid and jasmonic acid.

Authors:  Jing Shang; De-Hui Xi; Fei Xu; Shao-Dong Wang; Sen Cao; Mo-Yun Xu; Ping-Ping Zhao; Jian-Hui Wang; Shu-Dan Jia; Zhong-Wei Zhang; Shu Yuan; Hong-Hui Lin
Journal:  Planta       Date:  2010-11-03       Impact factor: 4.116

8.  HVEM Imprints Memory Potential on Effector CD8 T Cells Required for Protective Mucosal Immunity.

Authors:  Pritesh Desai; Georges Abboud; Jessica Stanfield; Paul G Thomas; Jianxun Song; Carl F Ware; Michael Croft; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

9.  A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.

Authors:  Michaël V Lukens; Alma C van de Pol; Frank E J Coenjaerts; Nicolaas J G Jansen; Vera M Kamp; Jan L L Kimpen; John W A Rossen; Laurien H Ulfman; Carline E A Tacke; Marco C Viveen; Leo Koenderman; Tom F W Wolfs; Grada M van Bleek
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

Review 10.  Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.

Authors:  James L Kreindler
Journal:  Pharmacol Ther       Date:  2009-11-10       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.